Literature DB >> 187767

Immunologic identification of Epstein-Barr virus early antigen in a P3HR-1 cell extract.

R W Veltri, W H Wainwright, P M Sprinkle.   

Abstract

We extracted the Epstein-Barr soluble antigen (EBSA) from the P3HR-1 human lymphoid cell line, which carries the Epstein-Barr virus (EBV), after P3HR-1 cells were activated with 5-iodo-2'-deoxyuridine. EBSA was identified as the early antigen (EA) complex by immunodiffusion and blocking immunofluorescence tests with high-titered human antiserum to EA. The identity of the EA complex was confirmed with antiserum to EA prepared in rabbits and adsorbed to assure its immunologic specificity. The EA was partially purified on Sephadex G-200. Further characterization by immunoelectrophoresis showed that the EBSA moved rapidly toward the anode. This indicated a highly negative charge. EBSA appeared to be distinct from the previously described complement-fixing S-antigen. It was demonstrable only in EA-producer lymphoid cell lines and reacted specifically with human antiserum to EA, whereas the S-antigen was found in all EBV-carrying lymphoid cell lines and reacted with all EBV antibody-positive human antisera.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 187767     DOI: 10.1093/jnci/57.2.245

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  3 in total

1.  Comparison of the immune response to Epstein-Barr virus and cytomegalovirus in sera and synovial fluids of patients with rheumatoid arthritis.

Authors:  M Musiani; M Zerbini; S Ferri; M Plazzi; G Gentilomi; M La Placa
Journal:  Ann Rheum Dis       Date:  1987-11       Impact factor: 19.103

2.  Immunological status to Epstein-Barr virus and cytomegalovirus in patients with genital condylomata.

Authors:  M Zerbini; M Musiani; G Gentilomi; S Costa; M G Poggi; M La Placa
Journal:  Eur J Epidemiol       Date:  1989-09       Impact factor: 8.082

3.  Detection of active Epstein-Barr infection in pregnant women.

Authors:  S Costa; R Barrasso; P Terzano; M Zerbini; C Carpi; M Musiani
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.